Cite
Makino I, Nakamura K, Sato Y, et al. Postmarketing surveillance of rabeprazole in upper gastrointestinal peptic lesions in Japanese patients with coexisting hepatic disorders. Curr Ther Res Clin Exp. 2006;67(1):1-20doi: 10.1016/j.curtheres.2006.02.003.
Makino, I., Nakamura, K., Sato, Y., Sato, Y., Sezai, S., Ikeda, Y., Shinmura, W., Watahiki, H., Yamamoto, H., Hioki, Y., Suzuki, M., Kumada, T., Honda, T., Rikitoku, T., Hisanaga, Y., Fukui, H., Yamao, J., Kawasaki, H., Hosoda, A., Onji, M., Matsui, H., Sata, M., Torimura, T., Oho, K., Maekawa, R., Takagi, Y., Shakado, S., Nakayama, M., Gondo, K., Fukushima, H., Kusaba, T., Tsubouchi, H., Hayashi, K., Hori, T., Iida, Y., Yutoku, K., Maetani, N., Kubo, Y., & Miyata, Y. (2006). Postmarketing surveillance of rabeprazole in upper gastrointestinal peptic lesions in Japanese patients with coexisting hepatic disorders. Current therapeutic research, clinical and experimental, 67(1), 1-20. https://doi.org/10.1016/j.curtheres.2006.02.003
Makino, Isao, et al. "Postmarketing surveillance of rabeprazole in upper gastrointestinal peptic lesions in Japanese patients with coexisting hepatic disorders." Current therapeutic research, clinical and experimental vol. 67,1 (2006): 1-20. doi: https://doi.org/10.1016/j.curtheres.2006.02.003
Makino I, Nakamura K, Sato Y, Sato Y, Sezai S, Ikeda Y, Shinmura W, Watahiki H, Yamamoto H, Hioki Y, Suzuki M, Kumada T, Honda T, Rikitoku T, Hisanaga Y, Fukui H, Yamao J, Kawasaki H, Hosoda A, Onji M, Matsui H, Sata M, Torimura T, Oho K, Maekawa R, Takagi Y, Shakado S, Nakayama M, Gondo K, Fukushima H, Kusaba T, Tsubouchi H, Hayashi K, Hori T, Iida Y, Yutoku K, Maetani N, Kubo Y, Miyata Y. Postmarketing surveillance of rabeprazole in upper gastrointestinal peptic lesions in Japanese patients with coexisting hepatic disorders. Curr Ther Res Clin Exp. 2006 Jan;67(1):1-20. doi: 10.1016/j.curtheres.2006.02.003. PMID: 24678081; PMCID: PMC3965972.
Copy
Download .nbib
